InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Postma Robert W, Director. Officer active across 2 companies, notably Ziopharm Oncology INC. In total, 12 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €501k. Activity tracked since 4 March 2021. The latest transaction was disclosed on 23 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Postma Robert W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
8,463 股@ US$1.92Common StockSEC:0001193125-26-318103:0
6,274 股@ US$2.590.31% mcap2.6% 占其流量Common StockSEC:0001193125-26-201489:0
5,622 股@ US$2.892.3% 占其流量Common StockSEC:0001193125-26-014116:0
5,142 股@ US$3.162.3% 占其流量Common StockSEC:0001193125-25-301026:0
4,050 股0Common StockSEC:0000950170-25-094387:0
20,804 股@ US$2.929.0% 占其流量Common StockSEC:0000950170-25-090587:0
20,804 股@ US$2.9210.2% 占其流量Common StockSEC:0000950170-25-054436:0
750,000 股@ US$0.6589.8% 占其流量Common StockSEC:0000899243-22-037275:0
标准退出：2023年2月27日 (T+90)
40,000 股0Common StockSEC:0000899243-22-023987:0
40,000 股0Common StockSEC:0000899243-22-024005:0
20,508 股@ US$1.73100.0% 占其流量Common StockSEC:0001209191-21-054825:0
标准退出：2021年12月1日 (T+90)
2,500 股0Common StockSEC:0001209191-21-030742:0
12 条申报中的 12 条
About Postma Robert W
Robert W. Postma is a Director at ZIOPHARM Oncology Inc and Alaunos Therapeutics, Inc. In this role, he participates in the governance of the companies and in strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions.
